(Total Views: 202)
Posted On: 02/19/2019 10:26:15 AM
Post# of 44017

$RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease @frontpagestocks https://finance.yahoo.com/news/regen-biopharm...00199.html

